This is a preview of subscription content, log in via an institution to check access.
References
Mancia G, et al. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. New England Journal of Medicine : 1 May 2020. Available from: URL: http://dx.doi.org10.1056/NEJMoa2006923
Reynolds HR, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. New England Journal of Medicine : 1 May 2020. Available from: URL: http://dx.doi.org/10.1056/NEJMoa2008975
Jarcho JA, et al. Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19. New England Journal of Medicine : 1 May 2020. Available from: URL: http://dx.doi.org/10.1056/NEJMe2012924
Rights and permissions
About this article
Cite this article
Risk of Covid-19 with renin-angiotensin-aldosterone system medications. Reactions Weekly 1804, 11 (2020). https://doi.org/10.1007/s40278-020-78440-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-78440-2